DUBLIN–(BUSINESS WIRE)–The “Respiratory Syncytial Virus Attachment Glycoprotein – Pipeline Review, H2 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. The report Respiratory Syncytial Virus Attachment Glycoprotein – Pipeline Review, H2 2019, outlays comprehensive information on the Respiratory Syncytial Virus Attachment Glycoprotein (RSV G or G) targeted therapeutics, complete with analysis by indications, stage of … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Physicians And Other Health Practitioners Global Market Forecast To 2022” report has been added to ResearchAndMarkets.com’s offering. The physicians and other health practitioners market consists of sales of physician and other health practitioners’ services and related goods by entities (organizations, sole traders and partnerships) that provide medical care services. This industry includes specialist … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Orthopedic Devices Global Market Forecast To 2022” report has been added to ResearchAndMarkets.com’s offering. The orthopedic devices (or) equipment market consists of sales of orthopedic devices and related services by entities (organizations, sole traders and partnerships) that produce orthopedic devices used in treating bone abnormalities. This industry includes establishments that produce devices used … [Read more…]

Ophthalmologist Jorn S. Jorgensen, CEO and Founder of EuroEyes, Implanted EVO ICLs in His Son, Jannik Jorgensen LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that Dr. Jorn S. Jorgensen successfully implanted the Company’s EVO Visian ICL … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Neuronal Acetylcholine Receptor Subunit Alpha 7 – Pipeline Review, H2 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. Neuronal Acetylcholine Receptor Subunit Alpha 7 (CHRNA7) pipeline Target constitutes close to 16 molecules. Out of which approximately 14 molecules are developed by companies and remaining by the universities/institutes. The latest report Neuronal Acetylcholine … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Cholera – Pipeline Review, H2 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. This latest Pharmaceutical and Healthcare disease pipeline guide Cholera – Pipeline Review, H2 2019, provides an overview of the Cholera (Infectious Disease) pipeline landscape. Report Highlights This Pharmaceutical and Healthcare latest pipeline guide Cholera – Pipeline Review, H2 2019, … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Global Surgical Robotics Market: Focus on Product Type, Brand-Value Matrix, Regulatory Framework, Awaited Technological Advancements, Patent Analysis, Insights on Emerging Platforms in Pipeline, and 43 Countries’ Data – Analysis and Forecast, 2019-2029” report has been added to ResearchAndMarkets.com’s offering. The global surgical robotics market is anticipated to witness tremendous growth over the forecast … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Lyme Disease – Pipeline Review, H2 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. The Lyme Disease – Pipeline Review, H2 2019, provides comprehensive information on the therapeutics under development for Lyme Disease (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) … [Read more…]

CAMBRIDGE, Mass.–(BUSINESS WIRE)–$sage #SageRx–Sage Therapeutics (NASDAQ:SAGE), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain, today announced it will host a live webcast on Tuesday, November 12, 2019 at 8:00 a.m. EST to report its third quarter 2019 financial results and … [Read more…]

GAINESVILLE, Fla.–(BUSINESS WIRE)–#ConceptCompanies—Concept Companies, a Gainesville headquartered full-service real estate development and construction firm, has announced commencement of construction on a new office and lab building in Copeland Park for Lacerta Therapeutics, a clinical-stage gene therapy company. The 12,950 square foot building is expected to be completed in the Spring of 2020. Strategically located in … [Read more…]